Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market
A continuum of services to suit every step of your project
Customer-centric CDMO:
Discover our flexible manufacturing solutions for biopharma companies
Biologics
Expert process development and manufacturing services for a diversity of biotherapeutics.
Bioconjugates
Flexible development and GMP manufacturing capacities for antibody-drug conjugates.
Nanodrugs
Integrated services for challenging API from formulation and development to GMP manufacturing.
Customer stories: What they were looking for in a CDMO
We’ve helped our customers develop and manufacture innovative therapies for more than 20 years.
Our expertise spans all stages of therapeutics development from R&D to commercial production
Over 20 years’ experience
Highly skilled collaborators
Different protein projects
%
GMP success rate over the past 10 years
GTP Bioways offers a continuum of services
Depending on you project, our production units will collaborate to offer you the best quality of service and work hand in hand from the start to move your project all the way from discovery lab bench to clinic.
Discover the expertise field of each production unit!
Saint-Julien
GTP Biologics
Toulouse
GTP Nano
Labège
GTP Tech
ISSOIRE
GTP Immuno
From our blog:Our CDMO experience at your service
From a project management perspective, what does it mean to be a full-service CDMO?
GTP Bioways is an experienced CDMO with a recognised expertise in the development and manufacturing of biologics (antibodies, proteins, bioconjugates and other complex biologics) and nanodrugs. Our...
Is your commercial HCP ELISA assay suitable to secure your bioprocess?
In early stages of biotherapeutic development, generic HCP ELISAs are an easy-to-use solution to quantify HCP content in DS and show HCP clearance through the DSP. However, HCP quantification can be...
COVID-19 vaccine race
Basic information about the COVID-19 vaccines based on World Health Organization data (available here). There are four main approaches to develop a vaccine against a virus, like SARS-CoV-2. All...